JBF Capital’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

JBF Capital’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-39,637	Closed	-$1.19K	–	93
2024 Q2	$1.19K	Buy	+39,637	New	+$588K	﹤0.01%	83

JBF Capital's MACK Position: Q3 2024 in Review

JBF Capital sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q3 2024, closing a stake of 39,637 shares — an estimated $1.19K sold.

JBF Capital first reported a position in MACK in Q2 2024 and held it in 1 quarter. The position peaked at $1.19K in Q2 2024. 2 funds tracked by Wall St. Rank hold MACK as of Q3 2024.

JBF Capital reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q3 2024 after selling out during the quarter.
JBF Capital sold 39,637 Merrimack Pharmaceuticals, Inc. shares in Q3 2024, an estimated $1.19K.
JBF Capital first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2024 and held it in 1 quarter.
JBF Capital's Merrimack Pharmaceuticals, Inc. position peaked at $1.19K in Q2 2024.
2 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q3 2024.

Based on JBF Capital's 13F filing for Q3 2024, filed 14 Nov 2024.